Lanreotide vs Octreotide LAR for Patients With Advanced Gastroenteropancreatic Neuroendocrine Tumors: An Observational Time and Motion Analysis

Journal of Oncology Pharmacy Practice - United States
doi 10.1177/1078155219839458
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications